Pediatrix Medical Group, Inc. (MD) stock
MDNYSEServices-HospitalsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 10/308% above fair value
$31.40−0.05 (-0.16%)
Close on Nov 12, 2026Market cap $2.45BP/E 17.1Yield –
Pediatrix Medical total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Pediatrix Medical's total debt was $577.72M at Sep 30, 2026. For fiscal 2025 it was $597.34M, down 3.3% from the year before. Over ten years it grew 36.3% a year on average. The highest annual figure on record is $1.70B in fiscal 2016.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $597.34M | -3.3% |
| FY2024 | Dec 31, 2024 | $617.66M | -2.5% |
| FY2023 | Dec 31, 2023 | $633.33M | -2.2% |
| FY2022 | Dec 31, 2022 | $647.28M | +25895.1% |
| FY2021 | Dec 31, 2021 | $2.49M | +884.2% |
| FY2018 | Dec 31, 2018 | $253.00K | -81.9% |
| FY2017 | Dec 31, 2017 | $1.40M | -99.9% |
| FY2016 | Dec 31, 2016 | $1.70B | +33.7% |
| FY2015 | Dec 31, 2015 | $1.27B | +123.9% |
| FY2014 | Dec 31, 2014 | $567.45M | +1994.5% |
| FY2013 | Dec 31, 2013 | $27.09M | +6015.6% |
| FY2009 | Dec 31, 2009 | $443.00K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $577.72M | -4.1% |
| Q2 FY2026 | Jun 30, 2026 | $584.24M | -3.8% |
| Q1 FY2026 | Mar 31, 2026 | $590.77M | -3.6% |
| Q4 FY2025 | Dec 31, 2025 | $597.34M | -3.3% |
| Q3 FY2025 | Sep 30, 2025 | $602.51M | +3025.7% |
| Q2 FY2025 | Jun 30, 2025 | $607.55M | +3326.7% |
| Q1 FY2025 | Mar 31, 2025 | $612.60M | +3633.3% |
| Q4 FY2024 | Dec 31, 2024 | $617.66M | -2.5% |
| Q3 FY2024 | Sep 30, 2024 | $19.28M | -97.0% |
| Q2 FY2024 | Jun 30, 2024 | $17.73M | -97.2% |
| Q1 FY2024 | Mar 31, 2024 | $16.41M | +10.0% |
| Q4 FY2023 | Dec 31, 2023 | $633.33M | -2.2% |
| Q3 FY2023 | Sep 30, 2023 | $636.62M | +4167.2% |
| Q2 FY2023 | Jun 30, 2023 | $640.19M | +4190.3% |
| Q1 FY2023 | Mar 31, 2023 | $14.91M | +499.0% |
| Q4 FY2022 | Dec 31, 2022 | $647.28M | +255741.5% |
| Q3 FY2022 | Sep 30, 2022 | $14.92M | +2688.6% |
| Q2 FY2022 | Jun 30, 2022 | $14.92M | +1635.1% |
| Q4 FY2021 | Dec 31, 2021 | $2.49M | +120.2% |
| Q4 FY2018 | Dec 31, 2018 | $253.00K | -81.9% |
| Q3 FY2018 | Sep 30, 2018 | $535.00K | -98.2% |
| Q2 FY2018 | Jun 30, 2018 | $860.00K | -96.8% |
| Q1 FY2018 | Mar 31, 2018 | $1.13M | -95.4% |
| Q4 FY2017 | Dec 31, 2017 | $1.40M | -99.9% |
| Q3 FY2017 | Sep 30, 2017 | $29.31M | – |
| Q2 FY2017 | Jun 30, 2017 | $27.04M | – |
| Q1 FY2017 | Mar 31, 2017 | $24.36M | – |
| Q4 FY2016 | Dec 31, 2016 | $1.70B | – |
See a number that looks wrong?